Want to see HCA full AI Analyst Report?

HCA Healthcare (HCA) Stock Forecast & Price Target

1,816 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

HCA Analyst Ratings

Moderate Buy

10 Buy

6 Hold

1 Sell

Based on 17 analysts giving stock ratings to

HCA

Healthcare

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

HCA Stock 12 Month Forecast

Average Price Target

$465.13

▼(-4.69% Downside)

Based on 17 Wall Street analysts offering 12 month price targets for HCA Healthcare in the last 3 months. The average price target is $465.13 with a high forecast of $558.00 and a low forecast of $370.00. The average price target represents a -4.69% change from the last price of $488.00.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"353":"$353","456":"$456","559":"$559","404.5":"$404.5","507.5":"$507.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":558,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$558.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":465.13333333333327,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$465.13</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":370,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$370.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[353,404.5,456,507.5,559],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,393.24,405.9138461538462,418.5876923076923,431.26153846153846,443.93538461538463,456.60923076923075,469.2830769230769,481.9569230769231,494.63076923076926,507.3046153846154,519.9784615384615,532.6523076923077,545.3261538461538,{"y":558,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,393.24,398.7702564102564,404.30051282051284,409.8307692307692,415.3610256410256,420.891282051282,426.42153846153843,431.95179487179485,437.48205128205126,443.0123076923077,448.54256410256403,454.07282051282044,459.60307692307686,{"y":465.13333333333327,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,393.24,391.4523076923077,389.6646153846154,387.8769230769231,386.08923076923077,384.3015384615385,382.51384615384615,380.72615384615386,378.9384615384615,377.15076923076924,375.3630769230769,373.5753846153846,371.7876923076923,{"y":370,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":386.904,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":354.564,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":401.237,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":423.955,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":457.398,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":500.503,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":465.234,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":495.119,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":531.064,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":473.8,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":432.223,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":370.218,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":393.24,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$558.00

Average Price Target$465.13

Lowest Price Target$370.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Andrew Cooper

Raymond James

―

Hold

―

Reiterated

07/15/26

Analysts Offer Insights on Healthcare Companies: Syndax Pharmaceuticals (NASDAQ: SNDX) and HCA Healthcare (NYSE: HCA)

Andrew Mok CFA

Barclays

$427→$402

Hold

-17.62%

Downside

Assigned

07/15/26

Barclays Reaffirms Their Hold Rating on HCA Healthcare (HCA)

David S Macdonald

Truist Financial

―

Buy

―

Reiterated

07/14/26

Analysts' Top Healthcare Picks: HCA Healthcare (HCA), Voyager Therapeutics (VYGR)

Ben Hendrix

RBC Capital

$534→$435

Buy

-10.86%

Downside

Reiterated

07/14/26

RBC Capital Sticks to Its Buy Rating for HCA Healthcare (HCA)

Craig Hettenbach

Morgan Stanley

$425

Sell

-12.91%

Downside

Reiterated

07/14/26

Analysts Offer Insights on Healthcare Companies: HCA Healthcare (NYSE: HCA) and Biogen (NASDAQ: BIIB)

Scott Fidel

Goldman Sachs

$520→$558

Buy

14.34%

Upside

Reiterated

07/14/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Sarah James

Cantor Fitzgerald

$525

Buy

7.58%

Upside

Reiterated

07/14/26

HCA Healthcare guidance cut likely to trigger selloff, says Cantor FitzgeraldHCA Healthcare guidance cut likely to trigger selloff, says Cantor Fitzgerald

Brian Tanquilut

Jefferies

$525→$450

Buy

-7.79%

Downside

Reiterated

07/14/26

HCA Healthcare price target lowered to $450 from $525 at JefferiesHCA Healthcare price target lowered to $450 from $525 at Jefferies

Matthew Gillmor CFA

KeyBanc

$510→$475

Buy

-2.66%

Downside

Reiterated

07/14/26

Analysts' Top Healthcare Picks: HCA Healthcare (HCA), Protagonist Therapeutics (PTGX)

Kevin Fischbeck

Bank of America Securities

$435→$370

Hold

-24.18%

Downside

Reiterated

07/14/26

Analysts Offer Insights on Healthcare Companies: HCA Healthcare (NYSE: HCA) and Cannara Biotech (Other OTC: LOVFF)

Ann Hynes

Mizuho Securities

$525

Buy

7.58%

Upside

Reiterated

07/13/26

HCA Healthcare (HCA) Receives a Buy from Mizuho Securities

Stephen Baxter

Wells Fargo

$436→$428

Hold

-12.30%

Downside

Reiterated

07/13/26

HCA Healthcare price target lowered to $428 from $436 at Wells FargoHCA Healthcare price target lowered to $428 from $436 at Wells Fargo

Ryan Langston

TD Cowen

$389.55→$431

Buy

-11.68%

Downside

Reiterated

06/25/26

Analysts Offer Insights on Healthcare Companies: HCA Healthcare (NYSE: HCA) and Icon (NASDAQ: ICLR)

Lance Wilkes

Bernstein

$413

Hold

-15.37%

Downside

Reiterated

06/09/26

Bernstein Reaffirms Their Hold Rating on HCA Healthcare (HCA)

Benjamin Rossi

J.P. Morgan

$490

Hold

0.41%

Upside

Reiterated

05/22/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: HCA Healthcare (NYSE: HCA) and Zai Lab (NASDAQ: ZLAB)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Andrew Cooper

Raymond James

―

Hold

―

Reiterated

07/15/26

Analysts Offer Insights on Healthcare Companies: Syndax Pharmaceuticals (NASDAQ: SNDX) and HCA Healthcare (NYSE: HCA)

Andrew Mok CFA

Barclays

$427→$402

Hold

-17.62%

Downside

Assigned

07/15/26

Barclays Reaffirms Their Hold Rating on HCA Healthcare (HCA)

David S Macdonald

Truist Financial

―

Buy

―

Reiterated

07/14/26

Analysts' Top Healthcare Picks: HCA Healthcare (HCA), Voyager Therapeutics (VYGR)

Ben Hendrix

RBC Capital

$534→$435

Buy

-10.86%

Downside

Reiterated

07/14/26

RBC Capital Sticks to Its Buy Rating for HCA Healthcare (HCA)

Craig Hettenbach

Morgan Stanley

$425

Sell

-12.91%

Downside

Reiterated

07/14/26

Analysts Offer Insights on Healthcare Companies: HCA Healthcare (NYSE: HCA) and Biogen (NASDAQ: BIIB)

Scott Fidel

Goldman Sachs

$520→$558

Buy

14.34%

Upside

Reiterated

07/14/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Sarah James

Cantor Fitzgerald

$525

Buy

7.58%

Upside

Reiterated

07/14/26

HCA Healthcare guidance cut likely to trigger selloff, says Cantor FitzgeraldHCA Healthcare guidance cut likely to trigger selloff, says Cantor Fitzgerald

Brian Tanquilut

Jefferies

$525→$450

Buy

-7.79%

Downside

Reiterated

07/14/26

HCA Healthcare price target lowered to $450 from $525 at JefferiesHCA Healthcare price target lowered to $450 from $525 at Jefferies

Matthew Gillmor CFA

KeyBanc

$510→$475

Buy

-2.66%

Downside

Reiterated

07/14/26

Analysts' Top Healthcare Picks: HCA Healthcare (HCA), Protagonist Therapeutics (PTGX)

Kevin Fischbeck

Bank of America Securities

$435→$370

Hold

-24.18%

Downside

Reiterated

07/14/26

Analysts Offer Insights on Healthcare Companies: HCA Healthcare (NYSE: HCA) and Cannara Biotech (Other OTC: LOVFF)

Ann Hynes

Mizuho Securities

$525

Buy

7.58%

Upside

Reiterated

07/13/26

HCA Healthcare (HCA) Receives a Buy from Mizuho Securities

Stephen Baxter

Wells Fargo

$436→$428

Hold

-12.30%

Downside

Reiterated

07/13/26

HCA Healthcare price target lowered to $428 from $436 at Wells FargoHCA Healthcare price target lowered to $428 from $436 at Wells Fargo

Ryan Langston

TD Cowen

$389.55→$431

Buy

-11.68%

Downside

Reiterated

06/25/26

Analysts Offer Insights on Healthcare Companies: HCA Healthcare (NYSE: HCA) and Icon (NASDAQ: ICLR)

Lance Wilkes

Bernstein

$413

Hold

-15.37%

Downside

Reiterated

06/09/26

Bernstein Reaffirms Their Hold Rating on HCA Healthcare (HCA)

Benjamin Rossi

J.P. Morgan

$490

Hold

0.41%

Upside

Reiterated

05/22/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: HCA Healthcare (NYSE: HCA) and Zai Lab (NASDAQ: ZLAB)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

KURAKura Oncology

CSTLCastle Biosciences

VKTXViking Therapeutics

ATECAlphatec Holdings

TRVITrevi Therapeutics

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering HCA Healthcare

3 Months

Whit MayoLeerink Partners

Success Rate

31/46 ratings generated profit

Average Return

+6.29%

Copying Whit Mayo's trades and holding each position for 3 Months would result in 67.39% of your transactions generating a profit, with an average return of +6.29% per trade.

1 Year

Scott FidelGoldman Sachs

Success Rate

24/27 ratings generated profit

Average Return

+18.27%

Copying Scott Fidel's trades and holding each position for 1 Year would result in 88.89% of your transactions generating a profit, with an average return of +18.27% per trade.

2 Years

Whit MayoLeerink Partners

Success Rate

44/46 ratings generated profit

Average Return

+50.08%

Copying Whit Mayo's trades and holding each position for 2 Years would result in 95.65% of your transactions generating a profit, with an average return of +50.08% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

HCA Analyst Recommendation Trends

Rating

Mar 26

Apr 26

May 26

Jun 26

Jul 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, HCA has received 16 Buy Ratings, 10 Hold Ratings, and 1 Sell Ratings. HCA average Analyst price target in the past 3 months is 465.13.

Each month's total comprises the sum of three months' worth of ratings.

HCA Financial Forecast

HCA Earnings Forecast

Next quarter’s earnings estimate for HCA is $7.52 with a range of $6.80 to $8.62. The previous quarter’s EPS was $7.15. HCA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate ― of the time in the same period. In the last calendar year HCA has its overall industry.

HCA Sales Forecast

Next quarter’s sales forecast for HCA is $19.68B with a range of $18.76B to $20.23B. The previous quarter’s sales results were $19.11B. HCA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates ― of the time in the same period. In the last calendar year HCA has its overall industry.

HCA Stock Forecast FAQ

What is HCA’s average 12-month price target, according to analysts?

Based on analyst ratings, Hca Healthcare’s 12-month average price target is 465.13.

What is HCA’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for HCA, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is HCA a Buy, Sell or Hold?

Hca Healthcare has a consensus rating of Moderate Buy which is based on 10 buy ratings, 6 hold ratings and 1 sell ratings.

What is Hca Healthcare’s price target?

The average price target for Hca Healthcare is 465.13. This is based on 17 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $558.00 ,the lowest forecast is $370.00. The average price target represents -4.69% Decrease from the current price of $488.

What do analysts say about Hca Healthcare?

Hca Healthcare’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 17 Wall Streets Analysts.

How can I buy shares of HCA?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

HCA Healthcare (HCA) Stock Forecast & Price Target

HCA Analyst Ratings

HCA Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering HCA Healthcare

HCA Analyst Recommendation Trends

HCA Financial Forecast

HCA Earnings Forecast

HCA Sales Forecast

HCA Stock Forecast FAQ

Detailed List of Analyst Forecasts